Added to YB: 2025-11-11
Pitch date: 2025-11-07
HIMS [neutral]
Hims & Hers Health, Inc.
-52.16%
current return
Author Info
Asymmetric Investing analyzes stocks that have an asymmetric return potential of 10x (or more) over the next decade. Sign up for the newsletter.
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$3.7B
Pitch Price
$42.49
Price Target
N/A
Dividend
N/A
EV/EBITDA
22.69
P/E
32.11
EV/Sales
1.83
Sector
Health Care Providers and Services
Category
growth
Hims & Hers: Taking the Long-Term View
HIMS (earnings): Q3'25 revenue +49% YoY, adj EBITDA +53%. Expanding beyond 'hair & ED' into GLP-1/GIP treatments, whole-genome sequencing, longevity platform launching 2026. Vertical integration with 1M+ sq ft FDA facilities cuts costs. International expansion to Canada, Brazil, UK. Tracking toward $6.5B rev/$1.3B EBITDA 2030 targets.
Read full article (4 min)